GlassScriptPhysician profile
Erica D Williams
NPI 1912953324
$389.33
in general payments reported to CMS, 2019-2025
12 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.21 · 2021: $15.81 · 2022: $84.41 · 2023: $44.82 · 2024: $32.82 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $223.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $131.70 | 2025 | Adstiladrin |
| Lilly USA, LLC | $48.76 | 2022-2024 | Mounjaro |
| Novo Nordisk INC | $43.83 | 2021-2025 | Wegovy |
| Amgen INC. | $38.73 | 2019 | |
| Bausch Health US, LLC | $18.91 | 2022 | |
| Medline Industries LP | $18.57 | 2023 | |
| Averitas Pharma INC. | $17.66 | 2024 | Qutenza |
| Axsome Therapeutics, INC. | $16.66 | 2022 | |
| Scynexis, INC. | $15.58 | 2022 | |
| Scilex Pharmaceuticals INC. | $14.40 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.45 | 2022 | |
| Endo Pharmaceuticals INC. | $12.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erica Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.